Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of the Korean Cancer Association
>
1991
>
23
>
2
Volume:
23
Issue:
2
1. Perineal pagent's disease involving the inguinoscrotal area.
Page:465—469
2. A case of congenital mesoblastic nephroma-diagnosed during intrauterine life.
Page:458—464
3. Gastroduodenal artery-duodenal fistula complicated during intraartrial chemotherapy for metastatic hepatic tumor.
Page:451—457
4. Intraglomerular malignant lymphomatosis: a report of a case-.
Page:443—450
5. Bilateral breast carcinoma.
Page:436—442
6. A computer program for survival analysis.
Page:429—435
7. Clinical evaluation of a totally implantable venous access system for long-term anticancer chemotherapy.
Page:424—428
8. A prospective randomized comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cisplatinum based combination chemotherapy.
Page:418—423
9. A clinical study of breast cancer.
Page:410—417
10. A clinical analysis of the thyroid nodule in male.
Page:402—409
11. Clinical analysis of the surgical thyroid disease in male.
Page:387—401
12. EAP combination chemotherapy in patients with advanced head and neck cancer.
Page:380—386
13. Pharyngo;aryngoesophagectomy with pharyngogastric anastomosis.
Page:375—379
14. Continent ileal reservoir after radical cystectomy for bladder tumor.
Page:366—374
15. A clinical analysis for the 92 cases of colorectal cancer in young male patients.
Page:357—365
16. Nonoperative chemoradiotherapy (FUMIR) for squamous cell carcinoma of the anal canal.
Page:350—356
17. Bleomycin, etoposide, cisplatin(BEF) combination chemotherapy for experimental germ cell tumor.
Page:343—349
18. The results of multimodality treatment in neuroblastoma.
Page:337—342
19. Modified COP-BLAM combination chemotherapy for the non-Hodgkin's lymphoma.
Page:331—336
20. Pancreatoduodenectomy for resectable periampullary tumor.
Page:323—330
21. 5-fluorouracil, epirubicin, cisplatin(FEP) and 5-fluorouracil, cisplatin(FP) combination chemotherapy for advanced pancreatic carcinoma.
Page:315—322
22. A phase II trial of combined sequential FP (5-FU+cisplatin) chemotheraphy and radiotherapy in locally advanced unresectable esophageal cancer.
Page:307—314
23. Smooth muscle tumors of the stomach: a clinical analysis-.
Page:299—306
24. Clinical evaluation of Borrmann type 4 gastric cancer.
Page:291—298
25. 5-fluorouracil and cisplatin(FP) combination chemotherapy in advanced gastric cancer patients treated previously with chemotherapy.
Page:279—290
26. Etoposide, adriamycin and cisplatin(EAP) chemotherapy in advanced gastric cancer.
Page:273—278
27. Analysis of survival curves of gastric cancer patients according to TNM classification.
Page:266—272
28. Antitumor activity of adriamycin and the analogue, THP-adriamycin and epirubicin, against human tumor cell lines.
Page:259—265
29. A clinical and electrophysiological studies of vincristine neurotoxicity.
Page:252—258
30. Immune status of the long term survived patients after gastric adenocarcinoma operation.
Page:247—251
31. Effect of growth factors and differentiation inducer DMSO on the anaplastic thyroid carcinoma cell line, SNU-80.
Page:237—246
32. Significance of thymidine kinase activity in the gastrointestinal cancers.
Page:230—236
33. Lymphokine-activated killer(LAK) cell activity in tumor-transplanted mice(I).
Page:218—229
34. Anti-tumor effects of mesima EX in various types of cancer patients.
Page:211—217
35. Mechanism of antitumor effect of ursolic acid from eriobotryo japonica.
Page:206—210
36. Antitumor effect of selected medicinal plant compounds to implanted sarcoma 180 in the mouse.
Page:197—205
37. In vivo antitumor effects of lactic acid bacteria on sarcoma 180 and mouse lewis lung carcinoma.
Page:188—196
38. Establishment of SNU cell lines: november 1989-august 1990.
Page:169—187
39. Effect of low dose ethanol on experimental hepatocarcinogenesis.
Page:161—168